HCA Healthcare Inc (NYSE:HCA)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group LLC in a research note issued to investors on Thursday. They presently have a $90.00 target price on the stock. Jefferies Group LLC’s price target indicates a potential upside of 11.04% from the company’s current price. Jefferies Group also issued estimates for HCA Healthcare’s Q3 2017 earnings at $1.51 EPS, Q4 2017 earnings at $2.06 EPS, Q4 2017 earnings at $1.80 EPS, FY2017 earnings at $6.49 EPS, FY2017 earnings at $7.05 EPS, FY2018 earnings at $7.70 EPS and FY2018 earnings at $7.46 EPS.

Several other brokerages have also recently issued reports on HCA. Argus cut their target price on HCA Healthcare from $100.00 to $93.00 and set a “buy” rating on the stock in a research report on Monday, August 14th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 target price on shares of HCA Healthcare in a research report on Friday, October 13th. Zacks Investment Research raised HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. BMO Capital Markets assumed coverage on HCA Healthcare in a research report on Monday, October 16th. They set an “outperform” rating and a $90.00 target price on the stock. Finally, BidaskClub cut HCA Healthcare from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 5th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $91.25.

HCA Healthcare (NYSE HCA) traded up 1.58% during midday trading on Thursday, reaching $81.05. The company’s stock had a trading volume of 3,793,204 shares. The firm has a 50 day moving average of $77.65 and a 200 day moving average of $81.88. The firm has a market cap of $29.28 billion, a P/E ratio of 10.86 and a beta of 0.62. HCA Healthcare has a 52-week low of $67.00 and a 52-week high of $91.03.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the Zacks’ consensus estimate of $1.80 by ($0.05). The business had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. During the same period in the previous year, the business earned $1.66 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. Analysts anticipate that HCA Healthcare will post $6.97 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Jefferies Group LLC Reiterates “Buy” Rating for HCA Healthcare Inc (HCA)” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/10/22/jefferies-group-llc-reiterates-buy-rating-for-hca-healthcare-inc-hca.html.

In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $79.87, for a total value of $171,720.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 6,450 shares of company stock valued at $511,163 over the last quarter. Company insiders own 2.90% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of HCA. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of HCA Healthcare by 14.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after purchasing an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in shares of HCA Healthcare by 35.1% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after acquiring an additional 320 shares during the last quarter. Atlantic Trust LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $118,000. Lee Financial Co bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $125,000. Finally, Acrospire Investment Management LLC lifted its stake in shares of HCA Healthcare by 14.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 73.76% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.